Treatment of dysautonomia in extrapyramidal disorders

Therapeutic Advances in Neurological Disorders

Volumn 3, Issue 1, 2010, Pages 53-67

  Ziemssen, Tjalf ^a   Reichmann, Heinz ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

autonomic dysfunction; dysautonomia; extrapyramidal disease; multiple system atrophy; Parkinson s disease; treatment

Indexed keywords

CAFFEINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DESMOPRESSIN; DOPAMINE RECEPTOR STIMULATING AGENT; EPHEDRINE; ERYTHROPOIETIN; FLUDROCORTISONE; GLYCERYL TRINITRATE; HYDRALAZINE; LEVODOPA; METOPROLOL; MIDODRINE; MINOXIDIL; NIFEDIPINE; PERGOLIDE MESILATE; PINDOLOL; PLACEBO; ROPINIROLE; SELEGILINE; SILDENAFIL; THREO 3,4 DIHYDROXYPHENYLSERINE; YOHIMBINE;

ANORECTAL DISEASE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONSTIPATION; DIAGNOSTIC ERROR; DIFFUSE LEWY BODY DISEASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSAUTONOMIA; DYSPHAGIA; ENTEROPATHY; ERECTILE DYSFUNCTION; EXTRAPYRAMIDAL SYNDROME; GASTROINTESTINAL DISEASE; HUMAN; HYPERTENSION; MOTOR DYSFUNCTION; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RECOMMENDED DRUG DOSE; REVIEW; SEXUAL FUNCTION; SHY DRAGER SYNDROME; STOMACH DISEASE; SUPINE HYPERTENSION; UROGENITAL TRACT DISEASE;

EID: 77952239465     PISSN: 17562856     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756285609348902     Document Type: Review

References (135)

1. Abbott, R.D., Petrovitch, H., White, L.R., Masaki, K.H., Tanner, C.M., Curb, J.D. et al. (2001) Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 57: 456-462.
2. Albanese, A., Brisinda, G., Bentivoglio, A.R. and Maria, G. ( 2003) Treatment of outlet obstruction constipation in Parkinson's Disease with botulinum neurotoxin A. Am J Gastroenterol 98: 1439-1440.
3. Andersen, E.B. and Boesen, F. ( 1997) Sympathetic vasoconstrictor reflexes in Parkinson's disease with autonomic dysfunction. Clin Auton Res 7: 5-11.
4. Andersen, J.T. ( 1985) Disturbances of bladder and urethral function in Parkinson's disease. Int Urol Nephrol 17: 35-41.
5. Appenzeller, O. and Goss, J.E. ( 1971) Autonomic deficits in Parkinson's syndrome. Arch Neurol 24: 50-57.
6. Ashraf, W., Wszolek, Z.K., Pfeiffer, R.F., Normand, M., Maurer, K., SRB, F. et al. (1995) Anorectal function in fluctuating (on-off) Parkinson's disease: evaluation by combined anorectal manometry and electromyography. Mov Disord 10: 650-657.
7. Baijens, L.W. and Speyer, R. (2009) Effects of therapy for dysphagia in Parkinson's disease: systematic review. Dysphagia 24: 91-102.
8. Barone, J.A. ( 1999) Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother 33: 429-440.
9. Benarroch, E.E., Schmeichel, A.M., Sandroni, P., Low, P.A. and Parisi, J.E. ( 2006) Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease. Neurology 66: 378-383.
10. Berger, Y., Blaivas, J.G., Delarocha, E.R. and Salinas, J.M. ( 1987) Urodynamic findings in Parkinson's disease. J Urol 138: 836-838.
11. Bleasdale-Barr, K.M. and Mathias, C.J. ( 1998) Neck and other muscle pains in autonomic failure: their association with orthostatic hypotension. J R Soc Med 91: 355-359.
12. Bonnet, A.M., Pichon, J., Vidailhet, M., Gouider-Khouja, N., Robain, G., Perrigot, M. et al. (1997) Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects. Mov Disord 12: 509-513.
13. Braak, H., Bohl, J.R., Muller, C.M., Rub, U., de Vos, R.A. and Del Tredici, K. ( 2006) Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord 21: 2042-2051.
14. Braak, H., Ghebremedhin, E., Rub, U., Bratzke, H. and Del Tredici, K. ( 2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318: 121-134.
15. Brown, E., Brown, G.M., Kofman, O. and Quarrington, B. ( 1978) Sexual function and affect in Parkinsonian men treated with L-dopa. Am J Psychiatry 135: 1552-1555.
16. Camerlingo, M., Ferraro, B., Gazzaniga, G.C., Casto, L., Cesana, B.M. and Mamoli, A. ( 1990) Cardiovascular reflexes in Parkinson's disease: long-term effects of levodopa treatment on de novo patients. Acta Neurol Scand 81: 346-348.
17. Chandiramani, V.A., Palace, J. and Fowler, C.J. ( 1997) How to recognize patients with Parkinsonism who should not have urological surgery. Br J Urol 80: 100-104.
18. Chaudhuri, K.R., Ellis, C., Love-Jones, S., Thomaides, T., Clift, S., Mathias, C.J. et al. (1997) Postprandial hypotension and Parkinsonian state in Parkinson's disease. Mov Disord 12: 877-884.
19. Churchyard, A., Mathias, C.J., Boonkongchuen, P. and Lees, A.J. ( 1997) Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease. J Neurol Neurosurg Psychiatry 63: 228-234.
20. Cleophas, T.J., Kauw, F.H., Bijl, C., Meijers, J. and Stapper, G. ( 1986) Effects of beta adrenergic receptor agonists and antagonists in diabetics with symptoms of postural hypotension: a double-blind, placebo-controlled study. Angiology 37: 855-862.
21. Dewey Jr, R.B., Rao, S.D., Holmburg, S.L. and Victor, R.G. ( 1998) Ergotamine / caffeine treatment of orthostatic hypotension in Parkinsonism with autonomic failure. Eur J Neurol 5: 593-599.
22. Djaldetti, R., Baron, J., Ziv, I. and Melamed, E. ( 1996) Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology 46: 1051-1054.
23. Edwards, L.L., Pfeiffer, R.F., Quigley, E.M., Hofman, R. and Balluff, M. ( 1991) Gastrointestinal symptoms in Parkinson's disease. Mov Disord 6: 151-156.
24. Ejaz, A.A., Kazory, A. and Heinig, M.E. ( 2007) 24-hour blood pressure monitoring in the evaluation of supine hypertension and orthostatic hypotension. J Clin Hypertens (Greenwich) 9: 952-955.
25. Ekberg, O., Hamdy, S., Woisard, V., Wuttge-Hannig, A. and Ortega, P. ( 2002) Social and psychological burden of dysphagia: its impact on diagnosis and treatment. Dysphagia 17: 139-146.
26. Fine, J. and Lang, A.E. ( 1999) Dose-induced penile erections in response to ropinirole therapy for Parkinson's disease. Mov Disord 14: 701-702.
27. Freeman, R. ( 2008) Clinical Practice. Neurogenic orthostatic hypotension. N Engl J Med 358: 615-624.
28. Friedenberg, F.K. and Parkman, H.P. ( 2006) Delayed gastric emptying: whom to Test, how to test, and what to do. Curr Treat Options Gastroenterol 9: 295-304.
29. Friedenberg, F.K. and Parkman, H.P. ( 2007) Advances in the management of gastroparesis. Curr Treat Options Gastroenterol 10: 283-293.
30. Friedrich, C., Rüdiger, H., Schmidt, C., Herting, B., Prieur, S., Junghanns, S. et al. (2008) Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes. J Neural Trans 115: 1527-1536.
31. Friedrich, C., Ruediger, H., Schmidt, C., Herting, B., Prieur, S., Junghanns, S. et al. (2009) Baroreflex sensitivity and power spectral analysis during autonomic testing in different extrapyramidal syndromes. Mov Disordin press.
32. Goetz, C.G., Lutge, W. and Tanner, C.M. ( 1986) Autonomic dysfunction in Parkinson's disease. Neurology 36: 73-75.
33. Goldstein, D.S. ( 2003) Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol 2: 669-676.
34. Goldstein, D.S. ( 2006) L-dihydroxyphenylserine (L-dops): A norepinephrine prodrug. Cardiovasc Drug Rev 24: 189-203.
35. Goldstein, D.S., Holmes, C., Li, S.T., Bruce, S., Metman, L.V. and Cannon 3rd, R.O. ( 2000) Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133: 338-347.
36. Goldstein, D.S., Holmes, C.S., Dendi, R., Bruce, S.R. and Li, S.T. ( 2002) Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology 58: 1247-1255.
37. Goldstein, D.S., Pechnik, S., Holmes, C., Eldadah, B. and Sharabi, Y. ( 2003) Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 42: 136-142.
38. Greenacre, J.K., Coxon, A., Petrie, A. and Reid, J.L. ( 1976) Comparison of levodopa with carbidopa or benserazide in Parkinsonism. Lancet 2: 381-384.
39. Hanson, J.C. and Lippa, C.F. ( 2009) Lewy body dementia. Int Rev Neurobiol 84: 215-228.
40. Hobson, P., Islam, W., Roberts, S., Adhiyman, V. and Meara, J. ( 2003) The risk of bladder and autonomic dysfunction in a community cohort of parkinson's disease patients and normal controls. Parkinsonism Relat Disord 10: 67-71.
41. Hunter, P.C., Crameri, J., Austin, S., Woodward, M.C. and Hughes, A.J. ( 1997) Response of Parkinsonian swallowing dysfunction to dopaminergic stimulation. J Neurol Neurosurg Psychiatry 63: 579-583.
42. Hussain, I.F., Brady, C.M., Swinn, M.J., Mathias, C.J. and Fowler, C.J. ( 2001) Treatment of erectile dysfunction with sildenafil citrate (viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 71: 371-374.
43. Jansen, R.W. and Lipsitz, L.A. ( 1995) Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 122: 286-295.
44. Jost, W.H. ( 1997) Gastrointestinal motility problems in patients with Parkinson's disease. Effects of antiparkinsonian treatment and guidelines for management. Drugs Aging 10: 249-258.
45. Jost, W.H. ( 2003) Autonomic dysfunctions in idiopathic Parkinson's disease. J Neurol 250(Suppl. 1): 128-130.
46. Jost, W.H. and Schimrigk, K. ( 1997) Long-term results with cisapride in Parkinson's disease. Mov Disord 12: 423-425.
47. Kanovsky, P., Bares, M., Pohanka, M. and Rektor, I. ( 2002) Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson's disease. J Neurol 249: 112-114.
48. Karsenty, G., Corcos, J., Schurch, B., Ruffion, A. and Chartier-Kastler, E. ( 2007) [Pharmacological treatment of neurogenic detrusor hyperactivity: intradetrusor botulinum toxin a injections]. Prog Urol 17: 568-575.
49. Kaufmann, H. ( 1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res 6: 125-126.
50. Kaufmann, H. and Biaggioni, I. ( 2003) Autonomic failure in neurodegenerative disorders. Semin Neurol 23: 351-363.
51. Kaufmann, H., Nahm, K., Purohit, D. and Wolfe, D. ( 2004) Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63: 1093-1095.
52. Kawakami, K., Abe, H., Harayama, N. and Nakashima, Y. ( 2003) Successful treatment of severe orthostatic hypotension with erythropoietin. Pacing Clin Electrophysiol 26: 105-107.
53. Kimber, J., Mathias, C.J., Lees, A.J., Bleasdale-Barr, K., Chang, H.S., Churchyard, A. et al. (2000) Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy. Brain 123: 1422-1430.
54. Kirchhof, K., Apostolidis, A.N., Mathias, C.J. and Fowler, C.J. ( 2003) Erectile and Urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int J Impot Res 15: 293-298.
55. Kollensperger, M., Seppi, K., Liener, C., Boesch, S., Heute, D., Mair, K.J. et al. (2007) Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy. Mov Disord 22: 1771-1776.
56. Korchounov, A., Kessler, K.R. and Schipper, H.I. ( 2004) Differential effects of various treatment combinations on cardiovascular dysfunction in patients with Parkinson's disease. Acta Neurol Scand 109: 45-51.
57. Kujawa, K., Leurgans, S., Raman, R., Blasucci, L. and Goetz, C.G. ( 2000) Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Arch Neurol 57: 1461-1463.
58. Kuroiwa, Y., Shimada, Y. and Toyokura, Y. ( 1983) Postural hypotension and low R-R interval variability in Parkinsonism, spino-cerebellar degeneration, and shy-drager syndrome. Neurology 33: 463-467.
59. Lamarre-Cliche, M., Souich, P., Champlain, J. and Larochelle, P. ( 2008) Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study. Clin Ther 30: 1629-1638.
60. Lemack, G.E., Dewey Jr, R.B., Roehrborn, C.G., O'Suilleabhain, P.E. and Zimmern, P.E. ( 2000) Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease. Urology 56: 250-254.
61. Lertxundi, U., Peral, J., Mora, O., Domingo-Echaburu, S., Martinez-Bengoechea, M.J. and Garcia-Monco, J.C. ( 2008) Antidopaminergic therapy for managing comorbidities in patients with Parkinson's disease. Am J Health Syst Pharm 65: 414-419.
62. Lewitt, P.A., Burns, R.S. and Calne, D.B. ( 1983) Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies. Adv Neurol 37: 131-140.
63. Lewy, F.H. ( 1913) Zur pathologischen anatomie der paralysis agitans. Dtsch Z Nervenheilk 50: 50-55.
64. Lieberman, A.N., Horowitz, L., Redmond, P., Pachter, L., Lieberman, I. and Leibowitz, M. ( 1980) Dysphagia in Parkinson's disease. Am J Gastroenterol 74: 157-160.
65. Logemann, J.A., Gensler, G., Robbins, J., Lindblad, A.S., Brandt, D., Hind, J.A. et al. (2008) A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson's disease. J Speech Lang Hear Res 51: 173-183.
66. Magalhaes, M., Wenning, G.K., Daniel, S.E. and Quinn, N.P. ( 1995) Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease - a retrospective comparison. Acta Neurol Scand 91: 98-102.
67. Maranki, J. and Parkman, H.P. ( 2007) Gastric electric stimulation for the treatment of gastroparesis. Curr Gastroenterol Rep 9: 286-294.
68. Mathias, C.J., Fosbraey, P., Da Costa, D.F., Thornley, A. and Bannister, R. ( 1986) The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed) 293: 353-354.
69. Mathias, C.J., Senard, J.M., Braune, S., Watson, L., Aragishi, A., Keeling, J.E. et al. (2001) L-threodihydroxyphenylserine (L-threo-dops; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 11: 235-242.
70. Maule, S., Papotti, G., Naso, D., Magnino, C., Testa, E. and Veglio, F. ( 2007) Orthostatic hypotension: evaluation and treatment. Cardiovasc Hematol Disord Drug Targets 7: 63-70.
71. McKee, R.F., McEnroe, L., Anderson, J.H. and Finlay, I.G. ( 1999) Identification of patients likely to benefit from biofeedback for outlet obstruction constipation. Br J Surg 86: 355-359.
72. Meco, G., Rubino, A., Caravona, N. and Valente, M. ( 2008) Sexual dysfunction in Parkinson's disease. Parkinsonism Relat Disord 14: 451-456.
73. Micieli, G., Tosi, P., Marcheselli, S. and Cavallini, A. ( 2003) Autonomic dysfunction in Parkinson's disease. Neurol Sci 24(Suppl. 1): S32-S34
74. Mitsui, J., Saito, Y., Momose, T., Shimizu, J., Arai, N., Shibahara, J. et al. (2006) Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123i-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease. J Neurol Sci 243: 101-104.
75. Nakajima, K., Yoshita, M., Matsuo, S., Taki, J. and Kinuya, S. ( 2008) Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders. Q J Nucl Med Mol Imaging 52: 378-387.
76. Naumann, M. and Jost, W. ( 2004) Botulinum toxin treatment of secretory disorders. Mov Disord 19(Suppl. 8): S137-S141
77. O'Sullivan, J.D. ( 2002) Apomorphine as an alternative to sildenafil in Parkinson's disease. J Neurol Neurosurg Psychiatry 72: 681.
78. Oertel, W.H., Wachter, T., Quinn, N.P., Ulm, G. and Brandstadter, D. ( 2003) Reduced genital sensitivity in female patients with multiple system atrophy of Parkinsonian type. Mov Disord 18: 430-432.
79. Oka, H., Morita, M., Onouchi, K., Yoshioka, M., Mochio, S. and Inoue, K. ( 2007a) Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson's disease. J Neurol Sci 254: 72-77.
80. Oka, H., Yoshioka, M., Morita, M., Onouchi, K., Suzuki, M., Ito, Y. et al. (2007 b) Reduced cardiac 123i-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease. Neurology 69: 1460-1465.
81. Pal, P.K., Calne, D.B., Calne, S. and Tsui, J.K. ( 2000) Botulinum toxin A as treatment for drooling saliva in PD. Neurology 54: 244-247.
82. Papatsoris, A.G., Papapetropoulos, S., Singer, C. and Deliveliotis, C. ( 2008) Urinary and erectile dysfunction in multiple system atrophy (MSA). Neurourol Urodyn 27: 22-27.
83. Parkinson, J. ( 1817) An Essay on Shaking Palsy, Sherwood, Neely and Jones: London.
84. Pathak, A., Raoul, V., Montastruc, J.L. and Senard, J.M. ( 2005) Adverse drug reactions related to drugs used in orthostatic hypotension: a prospective and systematic pharmacovigilance study in France. Eur J Clin Pharmacol 61: 471-474.
85. Pathak, A. and Senard, J.M. ( 2006) Blood pressure disorders during Parkinson's disease: epidemiology, pathophysiology and management. Expert Rev Neurother 6: 1173-1180.
86. Peralta, C., Stampfer-Kountchev, M., Karner, E., Kollensperger, M., Geser, F., Wolf, E. et al. (2007) Orthostatic hypotension and attention in Parkinson's disease with and without dementia. J Neural Transm 114: 585-588.
87. Pfeiffer, R.F. ( 2003) gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2: 107-116.
88. Pohanka, M., Kanovsky, P., Bares, M., Pulkrabek, J. and Rektor, I. ( 2004) Pergolide mesylate can improve sexual dysfunction in patients with Parkinson's disease: the results of an open, prospective, 6-month follow-up. Eur J Neurol 11: 483-488.
89. Polinsky, R.J. ( 1990) Clinical autonomic neuropharmacology. Neurol Clin 8: 77-92.
90. Pursiainen, V., Haapaniemi, T.H., Korpelainen, J.T., Sotaniemi, K.A. and Myllyla, V.V. ( 2007) Sweating in Parkinsonian patients with wearing-off. Mov Disord 22: 828-832.
91. Quinn, N., Illas, A., Lhermitte, F. and Agid, Y. ( 1981) Bromocriptine in Parkinson's disease: a study of cardiovascular effects. J Neurol Neurosurg Psychiatry 44: 426-429.
92. Rabine, J.C. and Barnett, J.L. ( 2001) Management of the patient with gastroparesis. J Clin Gastroenterol 32: 11-18.
93. Raffaele, R., Vecchio, I., Giammusso, B., Morgia, G., Brunetto, M.B. and Rampello, L. ( 2002) Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson's disease. Eur Urol 41: 382-386.
94. Reichmann, H. and Ziemssen, T. (2009) Treatment strategies for nonmotor manifestations of Parkinson's disease. Expert Opin Pharmacother 10: 773-784.
95. Reimann, M., Schmidt, C., Herting, B., Prieur, S., Junghanns, S., Schweitzer, K. et al. (2009) Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. J Neural Transmin press.
96. Robertson, D. ( 2008) The pathophysiology and diagnosis of orthostatic hypotension. Clin Auton Res 18(Suppl. 1): 2-7.
97. Robertson, D.R., Renwick, A.G., Macklin, B., Jones, S., Waller, D.G., George, C.F. et al. (1992) The influence of levodopa on gastric emptying in healthy elderly volunteers. Eur J Clin Pharmacol 42: 409-412.
98. Rub, U., Del Tredici, K., Schultz, C., de Vos, R.A., Jansen Steur, E.N., Arai, K. et al. (2002) Progressive supranuclear palsy: neuronal and glial cytoskeletal pathology in the higher order processing autonomic nuclei of the lower brainstem. Neuropathol Appl Neurobiol 28: 12-22.
99. Sachs, C., Berglund, B. and Kaijser, L. ( 1985) Autonomic cardiovascular responses in Parkinsonism: effect of levodopa with dopa-decarboxylase inhibition. Acta Neurol Scand 71: 37-42.
100. Sage, J.I. and Mark, M.H. ( 1994) Basic mechanisms of motor fluctuations. Neurology 44: S10-S14
101. Sakakibara, R., Hattori, T., Uchiyama, T., Kita, K., Asahina, M., Suzuki, A. et al. (2000) Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation ? J Neurol Neurosurg Psychiatry 68: 65-69.
102. Sakakibara, R., Hattori, T., Uchiyama, T. and Yamanishi, T. ( 2001) Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 71: 600-606.
103. Sakakibara, R., Uchiyama, T., Yamanishi, T., Shirai, K. and Hattori, T. ( 2008) Bladder and bowel dysfunction in Parkinson's disease. J Neural Transm 115: 443-460.
104. Schatz, I.J. ( 2002) Orthostatic hypotension predicts mortality. Lessons from the Honolulu Heart Program. Clin Auton Res 12: 223-224.
105. Schestatsky, P., Valls-Sole, J., Ehlers, J.A., Rieder, C.R. and Gomes, I. ( 2006) Hyperhidrosis in Parkinson's disease. Mov Disord 21: 1744-1748.
106. Schmidt, C., Herting, B., Prieur, S., Junghanns, S., Schweitzer, K., Globas, C. et al. (2007) Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes. Mov Disord 23: 2083-2089.
107. Schmidt, C., Herting, B., Prieur, S., Junghanns, S., Schweitzer, K., Globas, C. et al. (2008 a) Autonomic dysfunction in different subtypes of multiple system atrophy. Mov Disord 23: 1766-1772.
108. Schmidt, C., Herting, B., Prieur, S., Junghanns, S., Schweitzer, K., Globas, C. et al. (2009 a) Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord in press.
109. Schmidt, C., Herting, B., Prieur, S., Junghanns, S., Schweitzer, K., Globas, C. et al. (2009 b) Valsalva manoeuvre in patients with extrapyramidal disease. J Neural Transm 116: 875-880.
110. Schmidt, C., Herting, B., Prieur, S., Junghanns, S., Schweitzer, K., Reichmann, H. et al. (2008 b) Autonomic dysfunction in patients with progressive supranuclear palsy. Mov Disord 23: 2083-2089.
111. Schoffer, K.L., Henderson, R.D., O'Maley, K. and O'Sullivan, J.D. ( 2007) Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease. Mov Disord 22: 1543-1549.
112. Sharabi, Y., Imrich, R., Holmes, C., Pechnik, S. and Goldstein, D.S. ( 2008) Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension. Mov Disord 23: 1725-1732.
113. Shibao, C., Gamboa, A., Abraham, R., Raj, S.R., Diedrich, A., Black, B. et al. (2006 a) Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure. Hypertension 47: 522-526.
114. Shibao, C., Gamboa, A., Diedrich, A. and Biaggioni, I. ( 2006b) Management of hypertension in the setting of autonomic dysfunction. Curr Treat Options Cardiovasc Med 8: 105-109.
115. Stocchi, F., Badiali, D., Vacca, L., D'alba, L., Bracci, F., Ruggieri, S. et al. (2000) Anorectal function in multiple system atrophy and Parkinson's disease. Mov Disord 15: 71-76.
116. Stocchi, F., Barbato, L., Carbone, A., Fabbrini, G., Ruggieri, S., Bonamartini, A. et al. (1993) Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease. Adv Neurol 60: 434-437.
117. Swinn, L., Schrag, A., Viswanathan, R., Bloem, B.R., Lees, A. and Quinn, N. ( 2003) Sweating dysfunction in Parkinson's disease. Mov Disord 18: 1459-1463.
118. Tanner, C.M., Goetz, C.G., Glantz, R.H., Glatt, S.L. and Klawans, H.L. ( 1982) Pergolide mesylate and idiopathic Parkinson disease. Neurology 32: 1175-1179.
119. Thaisetthawatkul, P., Boeve, B.F., Benarroch, E.E., Sandroni, P., Ferman, T.J., Petersen, R. et al. (2004) Autonomic dysfunction in dementia with Lewy bodies. Neurology 62: 1804-1809.
120. Thanvi, B.R. and Lo, T.C. ( 2004) Long term motor complications of levodopa: clinical features, mechanisms, and management strategies. Postgrad Med J 80: 452-458.
121. Turkka, J., Suominen, K., Tolonen, U., Sotaniemi, K. and Myllyla, V.V. ( 1997) Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease. Neurology 48: 662-667.
122. Victor, R.G. and Talman, W.T. ( 2002) Comparative effects of clonidine and dihydroergotamine on venomotor tone and orthostatic tolerance in patients with severe hypoadrenergic orthostatic hypotension. Am J Med 112: 361-368.
123. Wakabayashi, K. and Takahashi, H. ( 2006) Cellular pathology in multiple system atrophy. Neuropathology 26: 338-345.
124. Wakabayashi, K., Takahashi, H., Ohama, E., Takeda, S. and Ikuta, F. ( 1993) Lewy bodies in the visceral autonomic nervous system in Parkinson's disease. Adv Neurol 60: 609-612.
125. Wenning, G.K., Ben-Shlomo, Y., Hughes, A., Daniel, S.E., Lees, A. and Quinn, N.P. ( 2000) What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 68: 434-440.
126. Wenning, G.K., Scherfler, C., Granata, R., Bosch, S., Verny, M., Chaudhuri, K.R. et al. (1999) Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed Parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 67: 620-623.
127. Witjas, T., Kaphan, E., Azulay, J.P., Blin, O., Ceccaldi, M., Pouget, J. et al. (2002) Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 59: 408-413.
128. Wittbrodt, E.T. and Kovalick, L.J. ( 1999) The use of oral vasopressors in the management of autonomic dysfunction and orthostatic hypotension. Ann Pharmacother 33: 565-571.
129. Yoshioka, M., Oka, H., Morita, M. and Inoue, K. ( 2003) [Sudomotor dysfunction in Parkinson's disease]. Rinsho Shinkeigaku 43: 379-384.
130. Yu, M., Roane, D.M., Miner, C.R., Fleming, M. and Rogers, J.D. ( 2004) Dimensions of sexual dysfunction in Parkinson disease. Am J Geriatr Psychiatry 12: 221-226.
131. Zangaglia, R., Martignoni, E., Glorioso, M., Ossola, M., Riboldazzi, G., Calandrella, D. et al. (2007) Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study. Mov Disord 22: 1239-1244.
132. Zesiewicz, T.A., Helal, M. and Hauser, R.A. ( 2000) Sildenafil citrate (viagra) for the treatment of erectile dysfunction in men with Parkinson's disease. Mov Disord 15: 305-308.
133. Ziemssen, T. and Reichmann, H. ( 2007) Non-motor dysfunction in Parkinson's disease. Parkinsonism Relat Disord 13: 323-332.
134. Ziemssen, T. and Reichmann, H. ( 2009) Cardiovascular autonomic dysfunction. J Neurol Sci, in press.
135. Ziemssen, T., Schmidt, C., Herting, B. and Reichmann, H. ( 2006) Autonomic dysfunction in Parkinson's disease and multiple system atrophy. Akt Neurol 33: 385-393.